Kim Kelderman - 15 Jul 2025 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Chief Executive Officer, Director
Signature
/s/ Andrew Nick, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed.
Issuer symbol
TECH
Transactions as of
15 Jul 2025
Net transactions value
-$91,683
Form type
4
Filing time
17 Jul 2025, 17:04:37 UTC
Previous filing
29 Jan 2025
Next filing
24 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kelderman Kim Chief Executive Officer, Director 614 MCKINLEY PLACE NE, MINNEAPOLIS /s/ Andrew Nick, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed. 17 Jul 2025 0001739054

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $1,601,732 +36,132 +93% $44.33 75,136 15 Jul 2025 Direct
transaction TECH Common Stock Tax liability $1,693,415 -32,933 -44% $51.42 42,203 15 Jul 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Stock Option (Right to Buy) Options Exercise $0 -36,132 -43% $0.000000 48,176 15 Jul 2025 Common Stock 36,132 $44.33 Direct F1
holding TECH Stock Option (Right to Buy) 109,536 15 Jul 2025 Common Stock 109,536 $47.60 Direct F1
holding TECH Stock Option (Right to Buy) 115,724 15 Jul 2025 Common Stock 115,724 $66.97 Direct F1
holding TECH Stock Option (Right to Buy) 25,944 15 Jul 2025 Common Stock 25,944 $120.46 Direct F2
holding TECH Performance Restricted Stock Units 6,984 15 Jul 2025 Common Stock 6,984 Direct F3, F4
holding TECH Performance Stock Options (Right to Buy) 21,704 15 Jul 2025 Common Stock 21,704 $94.52 Direct F4
holding TECH Stock Options (Right to Buy) 28,940 15 Jul 2025 Common Stock 28,940 $94.52 Direct F5
holding TECH Performance Restricted Stock Units 8,873 15 Jul 2025 Common Stock 8,873 Direct F3, F6
holding TECH Performance Stock Options (Right to Buy) 23,881 15 Jul 2025 Common Stock 23,881 $84.61 Direct F6
holding TECH Stock Options (Right to Buy) 29,391 15 Jul 2025 Common Stock 29,391 $84.61 Direct F7
holding TECH Stock Options (Right to Buy) 38,252 15 Jul 2025 Common Stock 38,252 $52.83 Direct F8
holding TECH Performance Restricted Stock Units 9,423 15 Jul 2025 Common Stock 9,423 Direct F3, F6
holding TECH Performance Stock Options (Right to Buy) 25,945 15 Jul 2025 Common Stock 25,945 $68.54 Direct F6
holding TECH Stock Options (Right to Buy) 51,890 15 Jul 2025 Common Stock 51,890 $68.54 Direct F9
holding TECH Performance Restricted Stock Units 51,261 15 Jul 2025 Common Stock 51,261 Direct F3, F10
holding TECH Restricted Stock Units 25,630 15 Jul 2025 Common Stock 25,630 Direct F3, F11
holding TECH Stock Options (Right to Buy) 69,061 15 Jul 2025 Common Stock 69,061 $74.91 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully exercisable.
F2 Options to purchase 6,484 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 6,488 shares vest on each of 8/6/2024 and 8/6/2025.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F4 Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F5 Options to purchase 7,236 shares vest on each of 8/15/2023, 8/15/2024 and 8/15/2026 and options to purchase 7,232 shares vest on 8/15/2025.
F6 Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F7 Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026.
F8 Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027.
F9 Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028.
F10 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F11 8,543 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027.
F12 Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028.